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PERINDOPRIL, A NEW A&$II;;$IN CONVERTING 
MYOCARDIAL 
~~~~~~~L~~IB~~~~ HEREDITARY CARD~OMYOPA- 
THY OF THE SYRIAN HAMSTER 
m Elizabeth Scalbert, Pierre Descht?, Yves Lecarpentier, 
INSERM U27i, LOA-ENSTA-Ecole Polyt&tgique, 91120 Palaiseau, 
France. 
We tested the hypothesis that chronic therapy with perindopril, *an 
angiotensinconvertingenzyme (ACE) inhibitor, exerts acardioprotecnve 
effect in the Syrian hamster strain Bio 53-58 developing a dilated car- 
diomyopathy (SHC). Twenty two 1 month-old SHC received at random 
either perindopril lmg/kg/day (PE) (n=ll) or placebo (C) (n=ll) by 
forcefeeding. Animals were studied at the age of 6 months. No overall 
mortality was observed. Serum ACE activity was inhibited by 68% in PE 
(6.3fo.7 mu/ml) as compared to C (19.8&0.5 mu/ml). Body weight was 
significantly lower in PE than in C (p=O.OOl) whereas the heart 
weight/body weight ratio was similar in both groups (pa.85). Myocardial 
mechanics of left ventricular papillary muscles were studied at Lmax, 
29’C, 2.5 mM extracellular calcium concentration and 3/min stimulation 
fnquency. The maximum unloaded shortening velocity (Vmax) was 
measured according to the zero-load clamp technique and was signifi- 
cantly greater in PE as compared to C (2.93ti.39 vs 1.68iO.30 Lmax/sec, 
p=O.O19). Conversely, noxmalized peak isometric force (F) was sirmlar 
in C and PE (1.44&0.27 vs 1.51fo.25 aWnm2). Both the time-to-peak 
shortening (139&5 vs 15 l&3 ms, p=O.O7) and time-to-peak force (12% 
vs 14244ms, p=O.OS) were decreased in PE compared lo C. The improved 
Vmax with an unchanged F suggests that the cardioprotective effect of 
perindopril is exerted via an increased myosin ATPase activity without 
modification of the total number of force-generating sites at the myofi- 
brillar level. This is the first report which showed that early therapy with 
an ACE inhibitor helped to preserve myocardial contractility of 
genetically cardiomyopathic hamster. 
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Evaluation and Treatment of Coronary Disease in the 
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8:30 
INTRACORONARY ULTRASOUND IN CARDIAC TRANSPLANT 
RECIPIENTS: IN VIVO EVALUATION OF ANGIOGRAPHICALLY 
SILENT INTIMAL THICKENING 
, Faust0 J. Pinto, Edwin L. Alderman, Hannah A. 
Valantine, Richard L. Popp. Stanford University, Stanford, CA. 
Accelerated coronary artery disease is a major cause of morbidity and 
mortality in cardiac transplant recipients. Histopathologic studies have 
demonstrated fibrous intimal thickening as early as one year after 
transplantation in angiographically normal vessels. Intravascular 
ultrasound (IVU) depicts coronary wall morphology and intimal 
thickening in wivo. To evaluate the ability of IW 10 document intimal 
thickening we studied 21 transplant recipients (mean age 44 f 14 years) 
undergorng routine arteriograms ranging from 3 weeks to 13 years after 
transplantaation. 82 coronary sites were imaged with a 30 mHz IVU 
catheter (3.9 sites/pt). 60 sites were angiogmphically normal. Sequential 
ultrasound image frames from each site were digitized over one cardiac 
cycle and dimensions quantified with a Dextra Medical Inc. image 
processor. Lumen area and the area of the lumen plus intima/intemal 
elastic lamina layer (IL) were measured at end-diastole. For each image 
both an intimal thickening index (IL minus lumen area divided by IL) and 
a mean IL thickness were calculated. Results: The four pts studied 
within one month of transplantation (donor ages 19, 23, 26, and 34 
years) had no IVU evidence of coronary wall layering. All patients 
studied 2 one year after transplantation had a measurable intimal layer by 
IVU. The 22 sites with angiographic evidence of coronary artery disease 
had a mean intimal index of 0.42 f 0.09 and mean intimal thickening of 
0.95 & 0.36 mm. The mean intimal index and mean incimal thickness of 
the 39 angiographically normal sites were 0.28 f 0.12 and 0.65 + 0.12 
mm nspe$vely and increased with time after transplaneation (r*=O.50). 
Conclusion: Intracoronary ultrasound successfully images intimal 
thickness in cardiac transplant recipients. In spite of normal 
aq$ographic appearance, by one year after transplantation all pts have 
intbal thickening by IW, and this appears to increase with advancing 
years. ‘Ibe absence of layering of the vessel wall in young, early post- 
transplant hearts suggests that normal intimal layer thickness falls below 
the resolution of 30 mH2 IVU. 
8:45 
LOW INCIDENCE OF ACCELERATED CORONARY SCLEROSIS IN 
CHILDREN UNDERGOING CARDIAC TRANSPLANTATION MAINTAINED ON 
CYCLOSPORIN AND AZATHIOPRINE ONLY. 
Rosemary Radley-Smith, Magdi Yacoub, Harefieid Hospital, 
Middlesex, England. 
Since August 1984, 80 children under the age of 15 years 
have undergone orthotopic cardiac transplantation at 
Harefield Hospital, for cardiomyopathy, in 60 patients and 
congenital heart disease in 20. Their ages were between 7 
days and 14 years. After transplan:ation, patients are 
maintained on cyclosporin A and azathioprine only. Routine 
steroids are not given. Forty-two patients have been 
followed up for more than 1 year (l-6 years) and 40 (95%) 
have undergone routine annual cadiac catheterisation and 
selective coronary angiography, irrespective of age, on 96 
occasions. Right heart pressures and left ventricular end 
diastolic pressure was normal in all patients. The 
selective coronary angiograms were reviewed by at least 2 
independent observers. The coronary arteries were judged 
to be normal in all 96(100%) angiograms, however the 1 
patient who did not undergo his routine angiogram at 12 
months, died at 18 months from coronary occlusion. This 
child was receiving 
condition. 
oral steroids for an unrelated 
It is concluded that, in the absence of routine oral 
steroids, accelerated coronary artery disease is rare 
In children after cardiac transplantat!on. 
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RELATIONSHIP OF PERSISTENTLY ELEVATED SOLUBLE 
INTERLEUKIN-2 LEWELS AFTER HEART TRANSPLANT TO ALLOGRAFT 
ARTERIOPATHY. 
James B. Young, Nancy T indsor, Neal S. Kleiman, Frank 
W. Smart, Beth Cocan 
College of Medicine, 
We have previously demonstrated that mortality and 
development of allograft atherosclerosis (AGAS) after 
heart transplant was predicted by early elevation of 
soluble interleukin-2 receptor levels (SILPR). This study 
was designed to determine whether AGAS Pts had 
persistence of SILZR elevation independent of rejection 
status. Serum for ELISA-determined SIL2R was obtained at 
the time of endomyocardial biopsy (BX) 1, 6, 12, 18 and 
24 months after heart transplant in 55 consecutive Pts 
surviving at least 30 days. During follow-up, 15 Pts 
(27%) developed AGAS documented by angiography or 
autopsy. Mean SIL2R level and BX score (McAllister scale 
O-101 are cornDared between Pts with normal arteries and 
the fiGAS groud: 
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Whereas mean heart BX score was no different durina 
follow-up of AGAS vs normal, AGAS Pts had higher mea; 
SIL2R levels at every assay. This observation provides 
further support to the hypothesis that allograft coronary 
arteriopathy seems an immunologic phenomenon because 
lymphocyte activation is related to its development. More 
aggressive immunotherapy after heart transplant might be 
warranted to attenuate AGAS if SIL2R leveis are noted to 
be consistently elevated post HTX. 
